BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Transave, Inc. 

11 Deer Park Drive, Suite 117

Monmouth Junction  New Jersey  08852  U.S.A.
Phone: 732-438-9434 Fax: 732-438-9435


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Insmed Incorporated (INSM) Acquires Transave, Inc. 12/2/2010 7:44:02 AM    More...
Transave, Inc.: ARIKACE(TM) Demonstrates Sustained Benefit in Multiple Studies and Over Multiple Cycles of Treatment of Pseudomonas Lung Infections in Cystic Fibrosis Patients 10/21/2010 11:58:55 AM    More...
Transave, Inc. ARIKACE(TM) Demonstrates Sustained Benefit in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 6/17/2010 12:00:12 PM    More...
Transave, Inc. Issued Key Composition of Matter Patent for ARIKACE(TM) 5/24/2010 8:31:12 AM    More...
Transave, Inc. Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 10/19/2009 10:42:56 AM    More...
Transave, Inc. Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections 9/14/2009 9:08:55 AM    More...
Transave, Inc. Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 6/25/2009 10:39:42 AM    More...
Transave, Inc. Completes Enrollment in Arikace(TM) Phase II Bronchiectasis Study 4/21/2009 8:54:16 AM    More...
Transave, Inc. Secures $12.5 Million in New Financing 10/2/2008 9:52:29 AM    More...
Transave, Inc. Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis 6/13/2008 9:51:14 AM    More...
1234

//-->